Direkt zum Inhalt
Merck
Alle Fotos(1)

Wichtige Dokumente

Gesamtdokumentation anzeigen

T-033

Supelco

exo-THC -Lösung

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Synonym(e):

exo-THC -Lösung

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C21H30O2
CAS-Nummer:
27179-28-8
Molekulargewicht:
314.46
EG-Nummer:
200-659-6
UNSPSC-Code:
41116107
NACRES:
NA.24

Qualität

certified reference material

Qualitätsniveau

300

Form

liquid

Leistungsmerkmale

Snap-N-Spike®/Snap-N-Shoot®

Verpackung

ampule of 1 mL

Hersteller/Markenname

Cerilliant®

drug control

psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)

Konzentration

1.0 mg/mL in methanol

Methode(n)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

Anwendung(en)

cannabis testing
cannabis testing

Format

single component solution

Lagertemp.

−20°C

SMILES String

CCCCCc1cc(O)c2C3CC(=C)CC[C@H]3C(C)(C)Oc2c1

InChI

1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h12-13,16-17,22H,2,5-11H2,1,3-4H3/t16?,17-/m1/s1

InChIKey

AOYYFUGUUIRBML-ZYMOGRSISA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

exo-THC, also known as ∆9-11-THC, occurs as an impurity of ∆9-THC formed during its synthesis.

Anwendung

The Certified Spiking Solution® is suitable for exo-THC testing by HPLC, GC/MS, or LC-MS/MS methods in forensic analysis, clinical toxicology, urine drug testing, and cannabis potency or impurity profiling testing applications. The Certified Reference Material (CRM) in solution can also be used as follows:
  • Analysis of 29 hemp-based veterinary products to measure the amount of cannabinoids, terpenes, and heavy metals by liquid chromatography-diode array detection/mass spectroscopy (LC-DAD/MS), headspace gas chromatography-flame ionization detection (HS-GC-FID), and inductive coupled plasma-mass spectroscopy (ICP-MS)
  • Identification of 24 non-psychoactive cannabinoids in Cannabis Sativa extracts by liquid chromatography-UV detector and using linear retention index (LRI) approach

Leistungsmerkmale und Vorteile

  • Fully characterized under ISO/IEC 17025 and ISO 17034 accreditation
  • Accompanied with a comprehensive Certificate of Analysis (CoA) with data on stability, homogeneity, accuracy of concentration, uncertainty, and traceability
  • Rigorously tested through real-time stability studies to ensure accuracy and shelf life
  • Gravimetrically prepared using qualified precision balances to ensure minimal uncertainty
  • Flame sealed under argon into ampoules for long-term shelf life
  • Offered in a convenient, DEA-exempt format to improve laboratory efficiency

Rechtliche Hinweise

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

C-045

Cannabidiol -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

C-046

Cannabinol -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

C-084

Cannabidiol-D3 -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-003

(−)-Δ9-THC-D3 -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-005

(−)-trans-Δ9-THC -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-011

(−)-Δ9-THC-D3 -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-032

(−)-Δ8-THC -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-047

(±)-Δ9-THC -Lösung, 100 μg/mL in heptane, ampule of 1 mL, Cerilliant®

C-150

Cannabichromenic Acid (CBCA) solution, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-153

Cannabionolsäure (CBNA) -Lösung, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

T-111

Tetrahydrocannabivarinsäure (THCVA) -Lösung, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-171

Cannabicyclolic Acid (CBLA) solution, 0.5 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-217

Hemp Compliance Mix solution, certified reference material, ampule of 1 mL, Cerilliant®

C-219

Cannabinoid Mixture (Neutrals) - 8 Component solution, 500 μg/mL in methanol (each analyte), certified reference material, ampule of 1 mL, Cerilliant®

T-151

THC-O-Acetate solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-220

Cannabinoid Mixture - 3 Component solution, 1 mg/mL in methanol ((each analyte)), certified reference material, ampule of 1 mL, Cerilliant®

T-154

(-)-exo-THC-D3 solution, 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-218

Cannabinoid Mixture (Acids) - 6 Component solution, 500 μg/mL (1% DIPEA and 0.05% Ascorbic acid in Acetonitrile,each analyte), certified reference material, ampule of 1 mL, Cerilliant®

T-112

11-Nor-9-carboxy-delta9-THCV solution, 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-244

Cannabichromenic Acid (CBCA) solution, 1 mg/mL (1% DIPEA and 0.05% Ascorbic acid in Acetonitrile), certified reference material, ampule of 1 mL, Cerilliant®

C-264

(±)-Cannabicyclolic Acid (CBLA) solution, 0.5 mg/mL (0.1% DIPEA, 0.05 Ascorbic Acid in Acetonitrile), certified reference material, ampule of 1 mL, Cerilliant®

T-182

THC-O-Acetate solution, 1 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

Signalwort

Danger

Gefahreneinstufungen

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Zielorgane

Eyes

Lagerklassenschlüssel

3 - Flammable liquids

WGK

WGK 1

Flammpunkt (°F)

49.5 °F - closed cup

Flammpunkt (°C)

9.7 °C - closed cup

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

E C Kearse et al.
Current eye research, 20(6), 496-501 (2000-09-12)
To determine the transcorneal flux, and intracorneal penetration, of Delta9-tetrahydrocannabinol when presented to the isolated rabbit cornea in different vehicles. Corneas were mounted in specular microscope chambers, with ( 3)H-Delta9-tetrahydrocannabinol on the epithelial surface in one of 15 vehicles and
D J Harvey et al.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology, 96(1), 65-69 (1990-01-01)
1. Liver microsomes were prepared from rats, rabbits, guinea pigs, hamsters, gerbils, a cat and three strains of mice, and were incubated with delta-11-tetrahydrocannabinol (delta-11-THC). The extracted metabolites were separated by chromatography on Sephadex LH-20 and examined by gas chromatography
David M Wilson et al.
Drug and alcohol dependence, 67(3), 259-267 (2002-07-20)
The goal of the present study was to formulate a Delta(9)-tetrahydrocannabinol (Delta(9)-THC) metered-dose inhaler (MDI) that can be used to provide a systemic dose of Delta(9)-THC via inhalation. Following physiochemical characterization and accelerated stability testing of the aerosol, mice were
T Rubino et al.
The European journal of neuroscience, 14(5), 884-886 (2001-09-29)
Here we describe, for the first time, the occurrence of behavioural sensitization after chronic exposure to Delta9-tetrahydrocannabinol. Rats were treated twice a day, for five days, with increasing doses (5, 10, 20, 40, 40 mg/kg i.p.) of Delta9-tetrahydrocannabinol or its
M Steffens et al.
British journal of pharmacology, 141(7), 1193-1203 (2004-03-03)
1. The present study investigated the binding characteristics of various ligands to cannabinoid CB(1) receptors in human neocortex and amygdala. In addition, the functionality of CB(1) receptors in the human neocortex was assessed by examining the effects of CB(1) receptor
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.